Prosight Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,815,652
| Closed | -$6.28M | – | 40 |
|
|
2025
Q1 | $6.28M | Sell |
2,815,652
-4,534,348
| -62% | -$10.1M | 2.06% | 20 |
|
|
2024
Q4 | $21.5M | Sell |
7,350,000
-1,729,539
| -19% | -$5.07M | 5.95% | 5 |
|
|
2024
Q3 | $23.6M | Buy |
9,079,539
+6,726,906
| +286% | +$17.5M | 5.81% | 4 |
|
|
2024
Q2 | $6.96M | Buy |
2,352,633
+562,633
| +31% | +$1.67M | 2.08% | 16 |
|
|
2024
Q1 | $8.11M | Buy |
1,790,000
+90,000
| +5% | +$408K | 2.26% | 14 |
|
|
2023
Q4 | $9.71M | Sell |
1,700,000
-746,000
| -30% | -$4.26M | 3.9% | 9 |
|
|
2023
Q3 | $11.3M | Sell |
2,446,000
-104,000
| -4% | -$478K | 3.57% | 9 |
|
|
2023
Q2 | $16.5M | Buy |
2,550,000
+1,796,472
| +238% | +$11.6M | 4.82% | 8 |
|
|
2023
Q1 | $5.68M | Buy |
753,528
+430,774
| +133% | +$3.25M | 2.69% | 16 |
|
|
2022
Q4 | $3.27M | Buy |
322,754
+236,250
| +273% | +$2.39M | 1.78% | 19 |
|
|
2022
Q3 | $856K | Buy |
+86,504
| New | +$856K | 0.46% | 33 |
|